We are live on
!
Find out more
Bessemer Group Portfolio holdings
AUM
$63.6B
1-Year Est. Return
28.76%
This Fund
S&P 500
This Quarter
Est. Return
+4.18%
1 Year Est. Return
+28.76%
3 Year Est. Return
+103.2%
5 Year Est. Return
+139.19%
10 Year Est. Return
+508.5%
AUM
$19.9B
AUM Growth
+$1.65B
(+9%)
Cap. Flow
+$899M
Cap. Flow
% of AUM
4.52%
Top 10 Holdings %
Top 10 Hldgs %
16.32%
Holding
1,955
New
652
Increased
403
Reduced
394
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$216M |
| 2 |
AGN
Allergan plc
AGN
|
+$174M |
| 3 |
Aramark
ARMK
|
+$161M |
| 4 |
JB Hunt Transport Services
JBHT
|
+$136M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$89.1M |
| 2 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$74.9M |
| 3 |
Walt Disney
DIS
|
+$73.4M |
| 4 |
Kimberly-Clark
KMB
|
+$63.9M |
| 5 |
Core Laboratories
CLB
|
+$63.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.78% |
| 2 | Healthcare | 13.07% |
| 3 | Technology | 12.41% |
| 4 | Consumer Discretionary | 11.47% |
| 5 | Industrials | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Boston Scientific
BSX
$65.8B
| $23K | ﹤0.01% |
984
| – | – |
|
1302
Korea Electric Power
KEP
$15.5B
| $23K | ﹤0.01% |
+926
| New | +$24.4K |
|
1303
Lennox International
LII
$18.8B
| $23K | ﹤0.01% |
+148
| New | +$23K |
|
1304
iShares TIPS Bond ETF
TIP
$14.5B
| $23K | ﹤0.01% |
+200
| New | +$23.2K |
|
1305
Vanguard Consumer Staples ETF
VDC
$7.86B
| $23K | ﹤0.01% |
167
| – | – |
|
|
SYT
1306
DELISTED
Syngenta Ag
SYT
| $23K | ﹤0.01% |
260
| – | – |
|
|
WBK
1307
DELISTED
Westpac Banking Corporation
WBK
| $23K | ﹤0.01% |
1,005
| – | – |
|
1308
HDFC Bank
HDB
$119B
| $22K | ﹤0.01% |
+1,212
| New | +$21.3K |
|
1309
RELX
RELX
$60.1B
| $22K | ﹤0.01% |
1,136
-844
| -43% | -$16.1K |
|
1310
iShares Silver Trust
SLV
$28.1B
| $22K | ﹤0.01% |
1,225
| – | – |
|
1311
Trex
TREX
$4.51B
| $22K | ﹤0.01% |
+1,480
| New | +$20.6K |
|
|
SPWR
1312
DELISTED
SunPower Corporation Common Stock
SPWR
| $22K | ﹤0.01% |
3,818
| – | – |
|
|
XLNX
1313
DELISTED
Xilinx Inc
XLNX
| $22K | ﹤0.01% |
416
-4,774
| -92% | -$245K |
|
|
HF
1314
DELISTED
HFF Inc.
HF
| $22K | ﹤0.01% |
+786
| New | +$21.8K |
|
|
LNCE
1315
DELISTED
Snyders-Lance, Inc.
LNCE
| $22K | ﹤0.01% |
646
+629
| +3,700% | +$21.8K |
|
|
LLTC
1316
DELISTED
Linear Technology Corp
LLTC
| $22K | ﹤0.01% |
+373
| New | +$20.9K |
|
|
EFOR
1317
Everforth Inc
EFOR
$845M
| $21K | ﹤0.01% |
589
| – | – |
|
1318
F5
FFIV
$22.1B
| $21K | ﹤0.01% |
+169
| New | +$20.5K |
|
1319
Flowserve
FLS
$9.25B
| $21K | ﹤0.01% |
427
-783,961
| -100% | -$37.2M |
|
1320
Fresenius Medical Care
FMS
$13.2B
| $21K | ﹤0.01% |
479
+245
| +105% | +$11K |
|
1321
TechnipFMC
FTI
$30.6B
| $21K | ﹤0.01% |
934
+220
| +31% | +$4.45K |
|
1322
Jazz Pharmaceuticals
JAZZ
$15.9B
| $21K | ﹤0.01% |
176
+14
| +9% | +$1.89K |
|
1323
Kadant
KAI
$3.69B
| $21K | ﹤0.01% |
+400
| New | +$21.3K |
|
1324
NOV
NOV
$7.45B
| $21K | ﹤0.01% |
572
-321,445
| -100% | -$10.8M |
|
1325
Saratoga Investment
SAR
$309M
| $21K | ﹤0.01% |
+1,171
| New | +$20.7K |
|
Similar funds
Bessemer Group's Q3 2016 Portfolio in Review
As of Q3 2016, Bessemer Group held 1,955 positions worth $19.9B, up 9% from $18.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bessemer Group deployed $899M of net new capital in Q3 2016, opening 652 new positions and adding to 403 existing holdings. Its largest new stake was Aramark: 6,077,645 shares worth $167M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Warner Bros, an estimated $89.1M trimmed.
- Bessemer Group's largest Q3 2016 buy was Aramark: 6,077,645 shares worth $167M.
- Bessemer Group added most to Amazon in Q3 2016, an estimated $216M increase.
- Bessemer Group's biggest Q3 2016 reduction was Warner Bros, cutting an estimated $89.1M.
- Bessemer Group fully exited Edwards Lifesciences in Q3 2016, selling an estimated $24.9M.
- Bessemer Group's ten largest holdings make up 16% of its $19.9B portfolio in Q3 2016.
- Bessemer Group opened 652 new positions and closed 149 in Q3 2016.
- Bessemer Group's portfolio value rose 9% quarter-over-quarter to $19.9B.
Based on Bessemer Group's 13F filing for Q3 2016, filed 10 Nov 2016.